U.S. ex rel. Fragoules v. Daiichi Sankyo: A global pharmaceutical company has agreed to a $39 million settlement with the federal government and 49 states, including Connecticut, over allegations that its executives paid kickbacks to induce physicians to prescribe drugs.
Connecticut is slated to receive $104,628 as part of the Medicaid portion of the settlement. The state will also receive an additional $79,550 to go toward state-funded prescription drug programs administered by the Connecticut Department of Social Services.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
